Cramer’s lightning round: Amicus Therapeutics is an ideal spec

Inmode Ltd: “It sells for incredibly cheap. … Frankly, I don’t get it, and that makes me want to look more into it, not just say buy.”

Exact Sciences Corp: “They’re losing too much money, to be honest. I’m baffled. … That’s what I don’t like about it.”